News

03.12.2024

EMSP Addresses MEP Interest Group on Critical MS Challenges in Europe

Elisabeth Kasilingam, CEO of the European Multiple Sclerosis Platform (EMSP), spoke at the MEP Interest Group on Brain Health and…

Reflecting on Progress: The EBV-MS Annual Consortium Meeting 2024

30.11.2024

On November 25th and 26th, the picturesque city of Rome played host to the Annual Consortium Meeting of the EBV-MS…

Could the Epstein-Barr Virus hold the key for treatment and prevention of MS? BEHIND-MS Explores New Research Frontier

29.11.2024

  This week, leading researchers, clinicians, and patient advocates gathered in Heidelberg for the first annual meeting of the BEHIND-MS…

15.11.2024

EMSP Advocates for Patient-Centered AI Development at Brain Innovation Days 2024

EMSP CEO, Elisabeth Kasilingam, joined leading experts at the Brain Innovation Days in Brussels on November 23-24 to discuss the…

EMSP at ECTRIMS 2024 – Key takeaways

24.10.2024

EMSP delegates actively participated in the 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis ECTRIMS…

Unlocking the Mystery of MS: New BEHIND-MS Project Video Released

30.09.2024

The BEHIND-MS project is proud to announce the release of a new video that introduces the project’s objectives and groundbreaking…

23.09.2024

Presenting Key Insights from the IMSS Survey at ECTRIMS 2024

We are excited to share that the European Multiple Sclerosis Platform (EMSP) has presented the preliminary findings from the Impact…

Engaging Expert Patients: MS CAB and EBV-MS Project Team Collaborate on Clinical Trial Design

12.07.2024

On June 19, 2024, the Multiple Sclerosis Community Advisory Board (MS CAB) met with the EBV-MS project research team for…

Preliminary Results of the Impact of Multiple Sclerosis Symptoms (IMSS) Survey Presented at RIMS Annual Conference

09.07.2024

The 29th annual RIMS Conference held between 27 and 29 June 2024, marked a significant milestone for the MS community…

1 2 3 28